866-997-4948(US-Canada Toll Free)

Immunochemistry Analyzers-Medical Devices Pipeline Assessment, 2019

Published By :

GlobalData

Published Date : Dec 2019

Category :

Medical Equipments

No. of Pages : 473 Pages

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Immunochemistry Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Immunochemistry Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables 10
1.2 List of Figures 18
2 Introduction 19
2.1 Immunochemistry Analyzers Overview 19
3 Products under Development 20
3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development 20
3.2 Immunochemistry Analyzers - Pipeline Products by Segment 21
3.3 Immunochemistry Analyzers - Pipeline Products by Territory 22
3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path 23
3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 24
3.6 Immunochemistry Analyzers - Ongoing Clinical Trials 25
4 Immunochemistry Analyzers - Pipeline Products under Development by Companies 26
4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 26
4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development 31
5 Immunochemistry Analyzers Companies and Product Overview 35
6 Immunochemistry Analyzers- Recent Developments 181
6.1 Nov 12, 2019: New breakthrough in Lyme Disease testing reduces time to results from days to minutes 181
6.2 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 181
6.3 Nov 06, 2019: Meridian submits Curian analyzer and the Curian HpSA assay to the FDA 184
6.4 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 184
6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 185
6.6 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 187
6.7 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 188
6.8 Oct 31, 2019: BioTek launches a set of quantitative assay apps to simplify detection-based applications 190
6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 190
6.10 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 191
6.11 Oct 31, 2019: SDI Group: Change of name 192
6.12 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance 192
6.13 Oct 30, 2019: Quidel reports third quarter 2019 financial results 193
6.14 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 194
6.15 Oct 30, 2019: Tecan appoints Ralf Griebel a member of the Management Board and Head of Partnering Business 196
6.16 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 196
7 Appendix 468
7.1 Methodology 468
7.2 About GlobalData 471
7.3 Contact Us 471
7.4 Disclaimer 471

List of Tables
Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 26
Table 2: Immunochemistry Analyzers - Pipeline Products by Segment 27
Table 3: Immunochemistry Analyzers - Pipeline Products by Territory 28
Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 29
Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 30
Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials 31
Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 32
Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development 37
Table 9: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 10: All-in-One Sensor - Product Status 41
Table 11: All-in-One Sensor - Product Description 41
Table 12: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43
Table 13: BioLED Device - Diabetes Management - Product Status 43
Table 14: BioLED Device - Diabetes Management - Product Description 43
Table 15: ADOR Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
Table 16: NATlab - Product Status 44
Table 17: NATlab - Product Description 44
Table 18: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 45
Table 19: AgPlus Diagnostic System - Product Status 45
Table 20: AgPlus Diagnostic System - Product Description 45
Table 21: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 22: minDNAnalyzer - Product Status 46
Table 23: minDNAnalyzer - Product Description 47
Table 24: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 25: TruDx 2000 Platform - Product Status 48
Table 26: TruDx 2000 Platform - Product Description 48
Table 27: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 28: Clondiag HIV Molecular Device - Product Status 49
Table 29: Clondiag HIV Molecular Device - Product Description 49
Table 30: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 31: BiliNow - Product Status 50
Table 32: BiliNow - Product Description 50
Table 33: PKU Now - Product Status 51
Table 34: PKU Now - Product Description 51
Table 35: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 36: ApoStream System - Product Status 52
Table 37: ApoStream System - Product Description 52
Table 38: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 39: Point Of Care Diagnostic Device - Phenylketonuria - Product Status 53
Table 40: Point Of Care Diagnostic Device - Phenylketonuria - Product Description 53
Table 41: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 54
Table 42: Atolyzer Consumer Device - Product Status 54
Table 43: Atolyzer Consumer Device - Product Description 54
Table 44: Atolyzer Gene - Product Status 55
Table 45: Atolyzer Gene - Product Description 55
Table 46: Atolyzer PoC - Product Status 55
Table 47: Atolyzer PoC - Product Description 56
Table 48: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 49: markB - Product Status 57
Table 50: markB - Product Description 57
Table 51: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 52: UniCel DxN - Product Status 59
Table 53: UniCel DxN - Product Description 59
Table 54: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 60
Table 55: U-PAC - Product Status 60
Table 56: U-PAC - Product Description 60
Table 57: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 58: Magnetic Immunoassay Detection System - Product Status 62
Table 59: Magnetic Immunoassay Detection System - Product Description 62
Table 60: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 61: TR-LFIA Diagnostic Analyzer - Product Status 64
Table 62: TR-LFIA Diagnostic Analyzer - Product Description 64
Table 63: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 64: MONITOR System - Product Status 65

List of Figures
Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 22
Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment 23
Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory 24
Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 25
Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 26
Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials 27

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *